SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-069486
Filing Date
2021-03-04
Accepted
2021-03-04 16:08:31
Documents
14
Period of Report
2021-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d150144d8k.htm   iXBRL 8-K 25058
2 EX-99.1 d150144dex991.htm EX-99.1 76079
6 GRAPHIC g150144g0302201551352.jpg GRAPHIC 2079
  Complete submission text file 0001193125-21-069486.txt   238734

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA chma-20210304.xsd EX-101.SCH 3084
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE chma-20210304_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chma-20210304_pre.xml EX-101.PRE 11417
7 EXTRACTED XBRL INSTANCE DOCUMENT d150144d8k_htm.xml XML 3454
Mailing Address 140 KENDRICK STREET BUILDING C EAST NEEDHAM MA 02494
Business Address 140 KENDRICK STREET BUILDING C EAST NEEDHAM MA 02494 617-928-5300
CHIASMA, INC (Filer) CIK: 0001339469 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37500 | Film No.: 21714214
SIC: 2834 Pharmaceutical Preparations